Icahn Enterprises L.P. IEP
6.96
0.01
0.14%
as of 25 Sep
- Market cap
- $4.9B
- P/E
- 0.0×
Follow IEP
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.51 | 0.44 | 0.48 | 0.45 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
322.77 | (10.08) | 12.11 | 41.58 | |
P/B ratio |
1.42 | 1.24 | 2.05 | 2.25 | |
Price to Tangible BV |
1.75 | 1.52 | 2.80 | 3.16 | |
EV/Sales |
0.57 | 0.54 | 0.63 | 0.62 | |
EV/EBITDA |
9.04 | 6.13 | 7.21 | 9.15 | |
EV/Operating CF |
15.53 | (16.58) | 23.57 | 60.96 | |
EV/FCF |
(26.67) | (6.10) | (24.59) | (25.99) | |
Quick Ratio |
4.18 | 4.10 | 2.61 | 2.81 | |
Current Ratio |
4.24 | 4.17 | 2.67 | 2.87 | |
Net Debt/EBITDA |
0.75 | 2.50 | (4.04) | (12.68) | |
Debt/Assets |
45.11% | 46.54% | 49.42% | 49.57% | |
Debt/Equity |
1.96 | 1.93 | 2.72 | 2.98 | |
Asset Turnover |
0.59 | 0.63 | 0.70 | 0.76 | |
Operating CF/Net income |
0.05 | (210.50) | (0.88) | (0.33) | |
Capex/Depreciation |
(0.55) | (0.39) | (0.93) | (0.65) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.00% | 7.82% | 9.47% | 6.82% | |
Intangible Assets out of Total Assets |
0.04 | 0.05 | 0.05 | 0.05 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.64) | (0.69) | (0.85) | (0.89) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(9.38%) | (7.95%) | (6.89%) | (10.26%) | |
Free Cash Flow Yield |
(4.23%) | (20.06%) | (5.30%) | (5.20%) | |
Revenue per Share |
4.74 | 4.80 | 3.46 | 4.45 | |
Operating CF per Share |
0.03 | (0.75) | 0.62 | 0.17 | |
Capex per Share |
(0.15) | (0.14) | (0.18) | (0.12) | |
Free Cash Flow per Share |
(0.13) | (0.88) | 0.44 | 0.05 | |
Cash per Share |
10.54 | 10.09 | 7.74 | 7.01 | |
Shareholders Equity per Share |
5.95 | 6.10 | 3.68 | 3.21 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.95 | 6.10 | 3.68 | 3.21 | |
Free Cash Flow |
(72.00) | (497.00) | 283.00 | 35.00 | |
Working Capital |
6,363.00 | 5,966.00 | 4,055.00 | 4,200.00 | |
Capital Expenditures |
(87.00) | (76.00) | (114.00) | (81.00) | |
Net Current Asset Value |
(3,079.00) | (2,941.00) | (4,096.00) | (4,299.00) | |
EV/EBIT |
80.40 | 21.27 | 24.02 | 57.72 | |
Capex to Sales |
0.03 | 0.03 | 0.05 | 0.03 | |
Net Profit Margin |
10.31% | 0.07% | (20.40%) | (11.70%) | |
Price to Operating Income |
71.20 | 17.39 | 18.43 | 42.69 | |
| Other line items | |||||
Average Receivables |
2,797.00 | 2,076.00 | 1,524.00 | 1,650.00 | |
Average Payables |
676.00 | 746.00 | 813.50 | 705.50 | |
Average Assets |
16,134.50 | 15,247.00 | 14,207.00 | 13,864.50 | |
Average Common Equity |
4,123.00 | 4,023.50 | 3,044.50 | 2,784.50 |
Columns are period end dates